Ypsomed Holding AG
YPSN
Clasificación en acciones
#2943
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and... Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
Precio por acción
$468.66
Capitalización bursátil
$6.16B
Cambio (1 día)
1.47%
Cambio (1 año)
18.80%
País
CH
Comercio Ypsomed Holding AG (YPSN)
Categoría
Healthcare
Ganancias de Ypsomed Holding AG (YPSN)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Ypsomed Holding AG, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Ypsomed Holding AG desde 2002 hasta 2026
Ganancias al final de cada año
| Año | Ganancias | Cambiar |
|---|---|---|
| 2025 | $117.99M | 30.03% |
| 2024 | $90.74M | 46.62% |
| 2023 | $61.89M | 123.73% |
| 2022 | $27.66M | 327.21% |
| 2021 | $6.48M | -20.72% |
| 2020 | $8.17M | -88.37% |
| 2019 | $70.22M | 8.04% |
| 2018 | $64.99M | 17.69% |
| 2017 | $55.22M | 23.00% |
| 2016 | $44.90M | 83.56% |
| 2015 | $24.46M | 41.99% |
| 2014 | $17.23M | 430.74% |
| 2013 | $3.25M | -69.86% |
| 2012 | $10.77M | 28.52% |
| 2011 | $8.38M | -25.03% |
| 2010 | $11.18M | -51.37% |
| 2009 | $22.98M | -23.06% |
| 2008 | $29.87M | 1,042.95% |
| 2007 | $2.61M | -94.71% |
| 2006 | $49.41M | 29.32% |
| 2005 | $38.20M | 235.81% |
| 2004 | $11.38M | 8.53% |
| 2003 | $10.48M | 159.63% |
| 2002 | $4.04M | 0.00% |
Ganancias de empresas similares o competidoras
| Empresa | Ganancias | Diferencia de ganancias | País |
|---|---|---|---|
| $1.09B | - |
IE
|
|
| - | - |
CN
|
|
| - | - |
CH
|
|
| - | - |
CN
|
|
| $74.36M | - |
KR
|
